Bisulfite Conversion and Sequencing of hCMV-MIE DNA
Corresponding Organization :
Other organizations : Roche Pharma AG (Germany), Ludwig-Maximilians-Universität München, Center for Integrated Protein Science Munich
Variable analysis
- Bisulphite treatment of genomic DNA extracted from recombinant CHO pools
- Methylation levels of the hCMV-MIE region as measured by bisulfite sequencing
- Concentration of amplified DNA measured with the Qubit system
- Library quality assessed using the Agilent 2100 bioanalyzer and High Sensitivity DNA Assay Kit
- Primers used for PCR amplification of bisulfite-converted hCMV-MIE DNA
- Sequencing platform (MiSeq system, Illumina)
- Bioinformatics tools used for read mapping (Bismark software, Bowtie2)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!